These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 17013463)

  • 1. Brain natriuretic peptide in heart failure and beyond.
    Mowla MM; Bustami BB
    Saudi Med J; 2006 Oct; 27(10):1457-61. PubMed ID: 17013463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of brain natriuretic peptide (BNP) in the diagnosis and treatment of heart failure].
    Martin-Du Pan RC; Ricou F
    Rev Med Suisse Romande; 2003 Feb; 123(2):125-8. PubMed ID: 15095695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BNP in the diagnosis and risk stratification of heart failure.
    Moe GW
    Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure.
    Bettencourt P; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):67-71. PubMed ID: 18243862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide show a different profile in response to acute decompensated heart failure treatment.
    Di Somma S; Magrini L; Tabacco F; Marino R; Talucci V; Marrocco F; Cardelli P; Ferri E; Pittoni V
    Congest Heart Fail; 2008; 14(5):245-50. PubMed ID: 18983287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natriuretic peptides in cardiovascular medicine.
    Munagala VK; Burnett JC; Redfield MM
    Curr Probl Cardiol; 2004 Dec; 29(12):707-69. PubMed ID: 15550914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial).
    Masson S; Latini R; Anand IS; Barlera S; Angelici L; Vago T; Tognoni G; Cohn JN;
    J Am Coll Cardiol; 2008 Sep; 52(12):997-1003. PubMed ID: 18786480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure.
    Cortés R; Rivera M; Salvador A; García de Burgos F; Bertomeu V; Roselló-Lletí E; Martínez-Dolz L; Payá R; Almenar L; Portolés M
    J Card Fail; 2007 Sep; 13(7):549-55. PubMed ID: 17826645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
    May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
    Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain natriuretic peptide release in cardiac surgery patients.
    Sinha AM; Breithardt OA; Schmid M; Stellbrink C
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):138-43. PubMed ID: 15926091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
    O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
    Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ; Zareba W; Bisognano JD
    Am J Cardiol; 2007 Apr; 99(8):1143-5. PubMed ID: 17437744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic significance of plasma N-terminal-pro-brain natriuretic peptide in decompensated heart failure with preserved ejection fraction.
    Paul B; Soon KH; Dunne J; De Pasquale CG
    Heart Lung Circ; 2008 Dec; 17(6):497-501. PubMed ID: 18722158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.